Rare Disease Report

Amicus Therapeutics Patient Advisory Board

AUGUST 06, 2013

Jayne Gershkowitz, Vice President, Patient Advocacy and Public Policy at Amicus Therapeutics recently spoke to Rare Disease Report about the patient programs that Amicus has in place to help both patients and Amicus improve their chances of success. Amicus is developing numerous orphan drugs for lysosomal storage disorders,  including Pompe and Fabry disease. For more information about some of the patient advocacy work Jayne discusses in this video, visit  www.amicusrx.com/patientadvisory.aspx

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.